VRTX

NASDAQ

Vertex Pharmaceuticals, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$113.78B

PE Ratio

27.8698

EV to Ebitda

21.017

Earnings Yield

3.59%

Revenue (TTM)

$12.07B

Net Income (TTM)

$3.95B

Revenue (Annual YoY Growth)

9.93%

Revenue (Quarterly YoY Growth)

11.76%

Profit Margin

32.74%

Return on Equity

22.97%

Debt to Equity Ratio

0.1091

Dividend Yield

0.00%

All fundamentals

Core8 fields›

Market Cap$113.78B

Revenue TTM$12.07B

Shares Outstanding254.0M

Float257689610

Insider Ownership0.96%

Volume1295147

Relative Strength40.5

GARP663

Growth Estimates16 fields›

Revenue Growth (Annual)9.93%

Revenue Growth (Quarterly YoY)11.76%

Operating Revenue Growth (Annual)0.216073

Operating Revenue Growth (Quarterly YoY)0.130413

3-Year Revenue Growth11.34%

5-Year Revenue Growth14.23%

EPS Growth (Annual)837.79%

EPS Growth (Quarterly YoY)32.70%

3-Year EPS Growth Rate6.12%

5-Year EPS Growth Rate8.28%

LT EPS Growth Estimates13.68%

EBITDA Growth (Annual)8.82%

EBITDA Growth (Quarterly YoY)19.47%

CFO Growth (Annual)837.19%

CFO Growth (Quarterly YoY)-14.81%

FCF Growth (Quarterly YoY)-29.15%

Operations28 fields›

Revenue TTM$12.07B

Gross Margin TTM86.32%

Gross Margin (Quarterly)85.56%

R&D % of Revenue TTM32.54%

R&D Expenses TTM$3.93B

Operating Margin TTM39.26%

Operating Margin (Quarterly)40.30%

Operating Expenses TTM$5.68B

Profit Margin TTM32.74%

Profit Margin (Quarterly)36.91%

Net Income TTM$3.95B

EPS TTM15.3349

EPS (Quarterly)4.6509

EBIT Margin TTM39.26%

EBIT Margin (Quarterly)40.30%

EBITDA Margin TTM40.98%

EBITDA Margin (Quarterly)41.94%

EBITDA TTM$4.95B

CFO % of Revenue TTM30.07%

CFO % of Revenue (Quarterly)15.43%

CFO TTM$3.63B

Cash Margin28.29%

Capex % of Revenue TTM3.62%

Capital Expenditures$437.6M

FCF % of Revenue TTM26.45%

FCF % of Revenue (Quarterly)10.80%

FCF TTM$3.19B

Fundamental Score9

Efficiency6 fields›

ROE22.97%

ROA16.33%

ROIC20.84%

CROCI16.83%

Stock Comp % (Quarterly)4.88%

Stock Comp % TTM5.68%

Valuation20 fields›

P/E (TTM)27.8698

P/E Forward22.3829

P/E Ex-Cash26.1727

P/S Forward8.3197

PEG Forward0.9094

P/CFO30.367

P/FCF34.5277

EV/EBITDA (TTM)21.017

EV/EBITDA Forward17.9773

EV/Revenues (TTM)8.6126

EV/Revenues Forward7.9691

EV/CFO30.4495

EV/FCF (TTM)32.5612

Price To Book5.8165

Price to Tangible Book6.9582

Earnings Yield3.59%

FCF Yield2.90%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score3

Relative to Industry10 fields›

Relative Gross Margin (Quarterly)1.0962

Relative P/E1.9024

Relative P/S1.4888

Relative P/B1.3033

Relative Earnings Yield0.5256

Relative Dividend Yield0

Relative ROE0.6883

Relative ROA0.9235

Relative ROIC0.8553

Relative Debt to Equity0.3193

Liquidity15 fields›

Cash Per Share26.0289

Current Ratio2.9009

Cash & ST Assets$6.61B

Total Debt$1.96B

Goodwill & Intangibles$1.51B

Total Assets$26.14B

Total Liabilities$7.48B

Shareholders Equity$18.67B

Debt to Equity0.1091

Debt to Assets7.79%

Interest Expense$13.3M

Times Interest Earned356.4586

CFO to Debt (TTM)2.064

Debt to EBITDA (TTM)0.3556

Goodwill % of Assets5.78%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield3.59%

Buyback Yield1.74%

Shareholder Yield1.58%

Options Flow8 fields›

Call Volume986

Put Volume445

Put/Call Ratio0.4513184584178499

Call $ Volume1203840

Put $ Volume285305

Put/Call $ Ratio0.23699578017012227

Call OI24570

Put OI22131